A new cognitive evaluation battery for Down syndrome and its relevance for clinical trials

dc.contributor.authorSola Llopis, Susana deca
dc.contributor.authorTorre Fornell, Rafael de laca
dc.contributor.authorSánchez Benavides, Gonzaloca
dc.contributor.authorBenejam, Bessyca
dc.contributor.authorCuenca Royo, Aida Ma, 1981-ca
dc.contributor.authorDel Hoyo Soriano, Lauraca
dc.contributor.authorRodríguez, Joanca
dc.contributor.authorCatuara Solarz, Silvina, 1986-ca
dc.contributor.authorSánchez Gutiérrez, Juditca
dc.contributor.authorDueñas-Espín, Iván, 1979-ca
dc.contributor.authorHernández, Gimenaca
dc.contributor.authorPeña-Casanova, J. (Jordi)ca
dc.contributor.authorLangohr, Klausca
dc.contributor.authorVidela, Sebastiàca
dc.contributor.authorBlehaut, Henryca
dc.contributor.authorFarré Albaladejo, Magíca
dc.contributor.authorDierssen, Maraca
dc.contributor.authorTESDAD Study Groupca
dc.date.accessioned2015-11-10T16:25:41Z
dc.date.available2015-11-10T16:25:41Z
dc.date.issued2015
dc.description.abstractThe recent prospect of pharmaceutical interventions for cognitive impairment of Down syndrome (DS) has boosted a number of clinical trials in this population. However, running the trials has raised some methodological challenges and questioned the prevailing methodology used to evaluate cognitive functioning of DS individuals. This is usually achieved by comparing DS individuals to matched healthy controls of the same mental age. We propose a new tool, the TESDAD Battery that uses comparison with age-matched typically developed adults. This is an advantageous method for probing the clinical efficacy of DS therapies, allowing the interpretation and prediction of functional outcomes in clinical trials. In our DS population the TESDAD battery permitted a quantitative assessment of cognitive defects, which indicated language dysfunction and deficits in executive function, as the most important contributors to other cognitive and adaptive behavior outcomes as predictors of functional change in DS. Concretely, auditory comprehension and functional academics showed the highest potential as end-point measures of therapeutic intervention for clinical trials: the former as a cognitive key target for therapeutic intervention, and the latter as a primary functional outcome measure of clinical efficacy. Our results also emphasize the need to explore the modulating effects of IQ, gender and age on cognitive enhancing treatments. Noticeably, women performed significantly better than men of the same age and IQ in most cognitive tests, with the most consistent differences occurring in memory and executive functioning and negative trends rarely emerged on quality of life linked to the effect of age after adjusting for IQ and gender. In sum, the TESDAD battery is a useful neurocognitive tool for probing the clinical efficacy of experimental therapies in interventional studies in the DS population suggesting that age-matched controls are advantageous for determining normalization of DS.ca
dc.format.mimetypeapplication/pdfca
dc.identifier.citationde Sola S, de la Torre R, Sánchez-Benavides G, Benejam B, Cuenca-Royo A, Del Hoyo L et al. A new cognitive evaluation battery for Down syndrome and its relevance for clinical trials. Front Psychol. 2015;6:708. DOI: 10.3389/fpsyg.2015.00708ca
dc.identifier.doihttp://dx.doi.org/10.3389/fpsyg.2015.00708
dc.identifier.issn1664-1078
dc.identifier.urihttp://hdl.handle.net/10230/25039
dc.language.isoengca
dc.publisherFrontiersca
dc.relation.ispartofFrontiers in psychology. 2015;6:708
dc.rights© 2015 de Sola, de la Torre, Sánchez-Benavides, Benejam, Cuenca- Royo, del Hoyo, Rodríguez, Catuara-Solarz, Sanchez-Gutierrez, Dueñas-Espin, Hernandez, Peña-Casanova, Langohr, Videla, Blehaut, Farre, Dierssen and The TESDAD Study Group.This is an open-access article distributed under the terms of the Creative Commons Attribution License (CCBY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licens or are credited and that the original publication in this journal is cited,in accordance with accepted academic practice. Nou se,distribution or reproduction is permitted which does not comply with these terms.ca
dc.rights.accessRightsinfo:eu-repo/semantics/openAccessca
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/ca
dc.subject.keywordTESDAD neuro cognitive battery
dc.subject.keywordIntellectual disabilities
dc.subject.keywordCognition
dc.subject.keywordClinical trials as topic
dc.subject.keywordDown syndrome
dc.subject.otherCognició -- Investigacióca
dc.subject.otherDown, Síndrome de -- Aspectes genèticsca
dc.titleA new cognitive evaluation battery for Down syndrome and its relevance for clinical trialsca
dc.typeinfo:eu-repo/semantics/articleca
dc.type.versioninfo:eu-repo/semantics/publishedVersionca

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Torre_fro_new.pdf
Size:
1.01 MB
Format:
Adobe Portable Document Format

License

Rights